Follow
John Wrangle
Title
Cited by
Cited by
Year
First-line nivolumab in stage IV or recurrent non–small-cell lung cancer
DP Carbone, M Reck, L Paz-Ares, B Creelan, L Horn, M Steins, E Felip, ...
New England Journal of Medicine 376 (25), 2415-2426, 2017
24362017
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
7542017
Combination epigenetic therapy has efficacy in patients with refractory advanced non–small cell lung cancer
RA Juergens, J Wrangle, FP Vendetti, SC Murphy, M Zhao, B Coleman, ...
Cancer discovery 1 (7), 598-607, 2011
7222011
Alterations of immune response of non-small cell lung cancer with azacytidine
J Wrangle, W Wang, A Koch, H Easwaran, HP Mohammad, F Vendetti, ...
Oncotarget 4 (11), 2067, 2013
3952013
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
JM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ...
The Lancet Oncology 19 (5), 694-704, 2018
3582018
Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum
A Hulbert, I Jusue-Torres, A Stark, C Chen, K Rodgers, B Lee, C Griffin, ...
Clinical Cancer Research 23 (8), 1998-2005, 2017
2502017
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Z Lu, J Zou, S Li, MJ Topper, Y Tao, H Zhang, X Jiao, W Xie, X Kong, ...
Nature 579 (7798), 284-290, 2020
2402020
Neutrophil‐to‐lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma
S Rachidi, K Wallace, JM Wrangle, TA Day, AJ Alberg, Z Li
Head & neck 38 (S1), E1068-E1074, 2016
1582016
Molecularly targeted therapies in non–small-cell lung cancer annual update 2014
D Morgensztern, MJ Campo, SE Dahlberg, RC Doebele, E Garon, ...
Journal of Thoracic Oncology 10 (1), S1-S63, 2015
1532015
Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO-1 predicts improved outcomes of anti–PD-1 therapies in metastatic melanoma
DB Johnson, J Bordeaux, JY Kim, C Vaupel, DL Rimm, TH Ho, ...
Clinical Cancer Research 24 (21), 5250-5260, 2018
1372018
IL-2 and beyond in cancer immunotherapy
JM Wrangle, A Patterson, CB Johnson, DJ Neitzke, S Mehrotra, ...
Journal of Interferon & Cytokine Research 38 (2), 45-68, 2018
1082018
Functional Identification of Cancer-Specific Methylation of CDO1, HOXA9, and TAC1 for the Diagnosis of Lung Cancer
J Wrangle, EO Machida, L Danilova, A Hulbert, N Franco, W Zhang, ...
Clinical Cancer Research 20 (7), 1856-1864, 2014
862014
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 2011; 1: 598–607. doi: 10.1158/2159-8290
RA Juergens, J Wrangle, FP Vendetti, SC Murphy, M Zhao, B Coleman, ...
Biomarkers for EGFR-Antagonist Response, 2011
802011
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events
B Keeley, A Stark, TR Pisanic II, R Kwak, Y Zhang, J Wrangle, S Baylin, ...
Clinica chimica acta 425, 169-175, 2013
542013
Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers
A Hulbert, CM Hooker, JC Keruly, T Brown, K Horton, E Fishman, ...
Journal of Thoracic Oncology 9 (6), 752-759, 2014
532014
Chemoprevention of squamous cell carcinoma of the head and neck
JM Wrangle, FR Khuri
Current Opinion in Oncology 19 (3), 180-187, 2007
502007
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer
CM Hooker, RA Meguid, A Hulbert, JT Taylor, J Shin, J Wrangle, ...
The Annals of thoracic surgery 93 (2), 405-412, 2012
492012
A phase 1–2 study of rovalpituzumab tesirine in combination with nivolumab plus or minus ipilimumab in patients with previously treated extensive-stage SCLC
J Malhotra, P Nikolinakos, T Leal, J Lehman, D Morgensztern, JD Patel, ...
Journal of Thoracic Oncology 16 (9), 1559-1569, 2021
482021
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity
K Majchrzak, MH Nelson, JS Bowers, SR Bailey, MM Wyatt, JM Wrangle, ...
JCI insight 2 (8), 2017
402017
Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20).
Z Piotrowska, HA Yu, JCH Yang, M Koczywas, EF Smit, DSW Tan, ...
Journal of Clinical Oncology 39 (15_suppl), 9077-9077, 2021
372021
The system can't perform the operation now. Try again later.
Articles 1–20